
Please try another search
Piramal Pharma Limited operates as a pharmaceutical company in the United States, Europe, Japan, India, and internationally. The company offers a portfolio of pharmaceutical products and services through global development and manufacturing facilities and distribution network. It also operates contract development and manufacturing organization that provides services across the drug life cycle, including discovery, development, and commercial manufacturing of drug substances and products; offers inhalation anesthetics, intrathecal therapy, injectable pain and anesthesia drugs, and other generic and specialty products; and analgesics, skin care, vitamin/mineral supplement, kids’ wellness, digestives, women’s health, and hygiene, as well as adult incontinence. The company was incorporated in 2020 and is based in Mumbai, India.
Name | Age | Since | Title |
---|---|---|---|
Subramanian Ramadorai | 80 | 2021 | Independent Non-Executive Director |
Vibha Paul Rishi | 64 | 2022 | Independent Non-Executive Director |
Peter Andrew Stevenson | 71 | 2022 | Independent Non-Executive Additional Director |
Nandini Ajay Piramal | 44 | 2020 | Executive Chairperson |
Nathalie Ann Leitch | 58 | 2025 | Non-Executive Non-Independent Director |
Sridhar Gorthi | 53 | 2022 | Independent Non-Executive Director |
Vivek Valsaraj | 52 | 2022 | CFO & Executive Director |
Amit Premchand Jain | - | 2025 | Non-Executive Director |
Peter Daniel DeYoung | 47 | 2020 | CEO of Piramal Global Pharma & Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review